CRBP Snapshot
Corbus Pharmaceuticals Holdings, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of novel therapies that target the endocannabinoid system in the fields of autoimmunity, fibrosis, and cancer. The company is headquartered in Norwood, Massachusetts.
VALUATION DATA
Market Capitalization$411,907,000
Price to Sales0.00
Earnings per Share$-10.3100
PE RatioNone
PRICE DATA
Most Recent Close$39.2400
52 Week High$163.32
52 Week Low$1490.79
50-Day Moving Average$8.26
200-Day Moving Average$-8.4
All data are from Alpha Vantage as of today. For more infomation on CRBP see Stock Dividend, Valuation, Price and Financial Data for Investors